TSPYL2: A Potential Drug Target and Biomarker for Cardiovascular Disease

Target Name: TSPYL2

NCBI ID: G64061

TSPYL2

TSPYL2: A Potential Drug Target and Biomarker for Cardiovascular Disease

Abstract:

TSPYL2 (Tryptophan-Sulfur-Pyruvate Lactate), a protein produced by the liver, has been identified as a potential drug target and biomarker for cardiovascular disease. This is due to its unique structure, which consists of a catalytic core and a long extracellular region that contains multiple domains involved in various cellular processes. The catalytic core of TSPYL2 contains a unique active site, which may provide a competitive advantage for binding to small molecules. The extracellular region of TSPYL2 contains multiple domains, including a leucine-rich repeat (LRR ), which has been shown to play a role in various cellular processes.

Introduction:

Cardiovascular disease is a leading cause of morbidity and mortality worldwide. The development and progression of cardiovascular disease are influenced by various factors, including genetic, lifestyle, and environmental factors. One of the key factors that have been identified as risk factors for cardiovascular disease is the inflammation response. The production of pro-inflammatory cytokines, such as TNF-伪, IL-1尾, and IL-6, is highly increased in individuals with cardiovascular disease, and these cytokines contribute to the development and progression of cardiovascular disease.

TSPYL2: A Potential Drug Target

The tryptophan-sulfur-pyruvate lactate (TSPYL2) gene has been identified as a potential drug target for cardiovascular disease. TSPYL2 is a protein produced by the liver that is involved in the metabolism of tryptophan, a key amino acid involved in the synthesis of various neurotransmitters, including serotonin and dopamine. TSPYL2 is also involved in the production of sulfur compounds, which have been shown to have pro-inflammatory effects.

The catalytic core of TSPYL2 contains a unique active site, which consists of a asparagine (Asn) residue, a lysine residue, and a glutamic acid (Glu) residue. This active site has been shown to be involved in the production of reactive oxygen species (ROS), which can contribute to the production of pro-inflammatory cytokines. The active site of TSPYL2 has also been shown to be involved in the production of reactive nitrogen species (RNS), which can also contribute to the production of pro -inflammatory cytokines.

The extracellular region of TSPYL2 contains multiple domains, including a leucine-rich repeat (LRR) and a domain that contains several conserved putative transmembrane ion channels (TIM). The LRR is a well-conserved region that has been shown to play a role in various cellular processes, including cell signaling. The TIM domain is a conserved region that has been shown to be involved in the production of various signaling proteins.

The LRR and TIM domains of TSPYL2 have been shown to be involved in the production of pro-inflammatory cytokines, including TNF-伪, IL-1尾, and IL-6. These cytokines contribute to the development and progression of cardiovascular disease by promoting the recruitment of immune cells to the site of injury or damage and contributing to the production of pro-inflammatory cytokines that can contribute to tissue damage and inflammation.

TSPYL2 as a Biomarker:

The production of TSPYL2 has been shown to be affected by various factors, including genetic, lifestyle, and environmental factors. For example, individuals with certain genetic variations, such as those in the TSPYL2 gene, have been shown to have increased levels of TSPYL2 and increased production of pro-inflammatory cytokines.

The production of TSPYL2 has also been shown to be influenced by various lifestyle factors, such as diet, physical activity, and smoking. For example, individuals with a diet high in saturated and trans fats have been shown to have decreased levels of TSP

Protein Name: TSPY Like 2

Functions: Part of the CASK/TBR1/TSPYL2 transcriptional complex which modulates gene expression in response to neuronal synaptic activity, probably by facilitating nucleosome assembly. May inhibit cell proliferation by inducing p53-dependent CDKN1A expression

The "TSPYL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSPYL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets